MIRAGEN THERAPEUTICS, INC. Human Resources Contracts & Agreements

Thomas Beetham Employment Agreement, dated October 27, 2023 (Filed With SEC on November 13, 2023)

Stephen Mahoney Employment Agreement, dated October 27, 2023 (Filed With SEC on November 13, 2023)

Viridian Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on June 16, 2023)

Jonathan Violin General Release and Separation and Consulting Agreement, dated February 6, 2023 (Filed With SEC on February 6, 2023)

Scott Myers Employment Agreement, dated December 29, 2022 (Filed With SEC on February 6, 2023)

Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive (Filed With SEC on August 15, 2022)

Carrie Melvin Employment Agreement, dated May 25, 2022 (Filed With SEC on June 23, 2022)

Kristian Humer Employment Agreement, dated June 9, 2021 (Filed With SEC on July 26, 2021)

Consulting Agreement, dated as of February 1, 2021, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on May 7, 2021)

Form of 2020 Incentive Stock Option Grant Notice under Viridian Therapeutics, Inc. 2020 Stock Incentive Plan (Filed With SEC on March 26, 2021)

Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on March 26, 2021)

Separation and Release Agreement, dated as of September 27, 2020 by and between the Registrant and Diana Escolar, M.D (Filed With SEC on March 26, 2021)

Employment Agreement by and between the Registrant and Barrett Katz, M.D., dated as of January 18, 2021 (Filed With SEC on March 26, 2021)

Separation and Release Agreement by and between the Company and Lee Rauch, dated as of January 15, 2020 (Filed With SEC on January 20, 2021)

Employment Agreement by and between the Company and Jonathan Violin, dated as of January 15, 2021 (Filed With SEC on January 20, 2021)

Bonus Agreement, dated as of September 14, 2020, by and between the Registrant and Jason Leverone (Filed With SEC on November 12, 2020)

Consulting Agreement, dated as of October 16, 2020, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on November 12, 2020)

Separation Agreement, dated as of October 15, 2020, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on November 12, 2020)

Bonus Agreement, dated as of September 27, 2020, by and between the Company and Diana Escolar, M.D (Filed With SEC on October 1, 2020)

Form of Bonus Agreement, dated as of September 14, 2020, by and between the Company and Diana Escolar, M.D (Filed With SEC on September 17, 2020)

Form of Bonus Agreement, dated as of September 14, 2020, by and between the Company and Jason Leverone (Filed With SEC on September 17, 2020)

Amended and Restated Employment Agreement, dated as of September 14, 2020, by and between the Company and Lee Rauch (Filed With SEC on September 17, 2020)

Form of Consulting Agreement, dated as of September 14, 2020, by and between the Company and William S. Marshall, Ph.D (Filed With SEC on September 17, 2020)

Form of Separation Agreement, dated as of September 14, 2020, by and between the Company and William S. Marshall, Ph.D (Filed With SEC on September 17, 2020)

Employment Agreement by and between the Registrant and Lee Rauch, dated as of June 16, 2020 (Filed With SEC on June 19, 2020)

Employment Agreement by and between the Registrant and Diana Escolar, M.D., dated as of February 20, 2020 (Filed With SEC on March 13, 2020)

Miragen Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2017)

MIRAGEN THERAPEUTICS, INC. RESTRICTED STOCK AWARD GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on May 11, 2017)

MIRAGEN THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2008 EQUITY INCENTIVE PLAN) (Filed With SEC on December 2, 2016)

MIRAGEN THERAPEUTICS, INC. 2008 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MAY 16, 2008; AMENDED JUNE 18, 2009; APRIL 9, 2012 AND OCTOBER 28, 2015 APPROVED BY THE... (Filed With SEC on December 2, 2016)

SIGNAL GENETICS, INC. 2016 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on December 2, 2016)

MIRAGEN THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on December 2, 2016)

SIGNALGENETICS, INC. RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 2, 2016)

SIGNALGENETICS, INC. STOCK OPTION GRANT AGREEMENT UNDER THE 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 2, 2016)

SIGNAL GENETICS, INC. RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 2, 2016)

Second AMENDMENT TO THE Signal Genetics, Inc.2014 Stock Incentive Plan (Filed With SEC on August 15, 2016)

FIRST AMENDMENT TO THE SIGNAL GENETICS, INC. 2014 STOCK INCENTIVE PLAN (Filed With SEC on June 23, 2015)